MedPath
NMPA Approval

Glecaprevir and Pibrentasvir Tablets

H20190035

May 15, 2019

Drug Information

格卡瑞韦哌仑他韦片

艾诺全

片剂

每片含格卡瑞韦100mg和哌仑他韦40mg

化学药品

May 15, 2019

May 14, 2024

Company Information

Applicant Company

Abbvie Corporation

8401 Trans-Canada Highway, Saint-Laurent, Québec, Canada, H4S 1Z1

Manufacturing Company

Anngrove, Carrigtwohill, County Cork, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

格卡瑞韦哌仑他韦片 - NMPA 批准文号 | MedPath